Free Trial

Vor Biopharma (VOR) News Today

$0.96
+0.01 (+1.06%)
(As of 12:33 PM ET)
Vor Biopharma logo with Medical background
Vor Biopharma (NYSE:VOR) Shares Down 7.3%
Vor Biopharma (NYSE:VOR) Shares Down 7.3%
Vor Biopharma Inc. (NYSE:VOR) Insider Eyal C. Attar Sells 14,645 Shares
Vor Biopharma Inc. (NYSE:VOR - Get Free Report) insider Eyal C. Attar sold 14,645 shares of the business's stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $1.39, for a total value of $20,356.55. Following the transaction, the insider now owns 96,063 shares of the company's stock, valued at approximately $133,527.57. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Vor Biopharma (NYSE:VOR) Trading 5.9% Higher
Vor Biopharma (NYSE:VOR) Shares Up 5.9%
Vor Biopharma (NYSE:VOR) Given "Market Outperform" Rating at JMP Securities
JMP Securities restated a "market outperform" rating and issued a $12.00 price objective on shares of Vor Biopharma in a report on Monday.
Vor Biopharma (NYSE:VOR) Receives Outperform Rating from Wedbush
Wedbush restated an "outperform" rating and set a $11.00 price objective on shares of Vor Biopharma in a research report on Friday.
Vor Biopharma (NYSE:VOR) Earns "Outperform" Rating from Wedbush
Wedbush reissued an "outperform" rating and set a $11.00 price objective on shares of Vor Biopharma in a report on Tuesday.
Stifel Nicolaus Sticks to Its Buy Rating for Vor Biopharma (VOR)
Vor Biopharma's (VOR) Market Outperform Rating Reaffirmed at JMP Securities
JMP Securities reiterated a "market outperform" rating and issued a $12.00 price objective on shares of Vor Biopharma in a research note on Friday.
Vor Biopharma Inc. Expected to Post Q1 2025 Earnings of ($0.24) Per Share (NYSE:VOR)
Vor Biopharma Inc. (NYSE:VOR - Free Report) - Equities researchers at Wedbush issued their Q1 2025 earnings estimates for Vor Biopharma in a research report issued on Wednesday, March 20th. Wedbush analyst D. Nierengarten expects that the company will post earnings per share of ($0.24) for the qu
Vor Biopharma (NYSE:VOR) Price Target Cut to $12.00 by Analysts at Stifel Nicolaus
Stifel Nicolaus dropped their price target on Vor Biopharma from $15.00 to $12.00 and set a "buy" rating on the stock in a research note on Thursday.
Oppenheimer Reaffirms "Outperform" Rating for Vor Biopharma (NYSE:VOR)
Oppenheimer restated an "outperform" rating and set a $15.00 price target (down from $17.00) on shares of Vor Biopharma in a report on Thursday.
Vor Biopharma: Q4 Earnings Insights
Vor Biopharma (VOR) to Release Quarterly Earnings on Thursday
Vor Biopharma (NYSE:VOR) will be releasing earnings on Thursday, March 21, Yahoo Finance reports.
VOR Apr 2024 5.000 call
Vor Biopharma's (VOR) "Outperform" Rating Reiterated at Wedbush
Wedbush reiterated an "outperform" rating and set a $11.00 price objective on shares of Vor Biopharma in a research report on Thursday.
Vor Biopharma Inc. (NYSE:VOR) Given Consensus Rating of "Buy" by Analysts
Shares of Vor Biopharma Inc. (NYSE:VOR - Get Free Report) have been given a consensus rating of "Buy" by the seven research firms that are currently covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month price target am
Get Vor Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for VOR and its competitors with MarketBeat's FREE daily newsletter.

New Biden Law just went into effect (Ad)

Congress has allocated $400 billion to support this law, and is considering approving billions more by the end of this year. And leaders from both sides of the aisle just issued a joint statement calling the signing of this law “a momentous day” for America – and critical to national security.

You can view his briefing by clicking here.

VOR Media Mentions By Week

VOR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VOR
News Sentiment

0.00

0.93

Average
Medical
News Sentiment

VOR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VOR Articles
This Week

1

1

VOR Articles
Average Week

Get Vor Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for VOR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:VOR) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners